Drugs for heartburn, gout and depression now being tested as coronavirus treatments
The search for existing drugs that may help patients beat back coronavirus infections now has researchers testing the heartburn drug Pepcid, among others. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - May 2, 2020 Category: Science Authors: Melissa Healy Source Type: news
Drugs for heartburn, gout and depression now being tested as coronavirus treatments
The search for existing drugs that may help treat coronavirus infections now has researchers testing the heartburn drug Pepcid, among others. (Source: L.A. Times - Health)
Source: L.A. Times - Health - May 2, 2020 Category: Consumer Health News Authors: Melissa Healy Source Type: news
New York's Northwell Health Testing Potential Heartburn Treatment for COVID-19 New York's Northwell Health Testing Potential Heartburn Treatment for COVID-19
When Dr. Kevin Tracey of Northwell Health ' s Feinstein Institutes for Medical Research got a call from a colleague who had been in Wuhan, China, seeing patients with COVID-19, the disease caused by the novel coronavirus, in January, his curiosity was piqued.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 29, 2020 Category: Gastroenterology Tags: Infectious Diseases News Source Type: news
People are hoarding a heartburn drug before scientists have determined whether it can fight coronavirus
Walgreens and CVS confirmed that they are experiencing shortages. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 29, 2020 Category: Consumer Health News Authors: Meryl Kornfield Source Type: news
Researchers studying a common heartburn drug as treatment for Covid-19
Hospitals in New York are giving Covid-19 patients the heartburn medicine famotidine to see if it helps fight the virus, according to the doctor who initiated the trial. (Source: CNN.com - Health)
Source: CNN.com - Health - April 27, 2020 Category: Consumer Health News Source Type: news
AHA News: Cancer Survivor Feared Recurrence, But This Time It Was His Heart
Monday, April 6, 2020 (American Heart Association News) -- Doug Cobb popped a couple antacid pills to calm the heartburn he ' d been experiencing on and off for weeks. The 60-year-old considered he might have a stomach problem, but waved it off,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 6, 2020 Category: General Medicine Source Type: news
FDA Pulls Heartburn Drug Zantac From Market
Title: FDA Pulls Heartburn Drug Zantac From MarketCategory: Health NewsCreated: 4/1/2020 12:00:00 AMLast Editorial Review: 4/2/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - April 2, 2020 Category: Nutrition Source Type: news
Zantac, Ranitidine Pulled From Market, Here Are FDA ’s Latest Cancer Concerns
New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration ' s (FDA ' s) more drastic action. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 2, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news
FDA Requests Zantac Be Pulled From the Market
Six months after independent testing first raised the possibility that popular heartburn drug ranitidine (Zantac) might break down into the powerful carcinogen n-nitrosodimethylamine (NDMA), the FDA has asked for the removal of all ranitidine products from the market. (Source: WebMD Health)
Source: WebMD Health - April 2, 2020 Category: Consumer Health News Source Type: news
US drugs regulator calls for halt to Zantac sales
Heartburn medication made by Sanofi of France has been linked to cancer-causing impurity (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 1, 2020 Category: Pharmaceuticals Source Type: news
Zantac, other heartburn drugs recalled over possible cancer link
FDA orders drugmakers to pull popular heartburn medications that contain trace amounts of a carcinogen. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 1, 2020 Category: Consumer Health News Source Type: news
FDA calls for heartburn drug Zantac to be pulled from market immediately
The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - April 1, 2020 Category: Consumer Health News Source Type: news
FDA wants heartburn meds off the market due to contamination
The U.S. Food and Drug Administration is telling drugmakers to immediately pull a type of heartburn drug off the market due to contamination with a chemical that may cause cancer (Source: ABC News: Health)
Source: ABC News: Health - April 1, 2020 Category: Consumer Health News Tags: Health Source Type: news
FDA Pulls Heartburn Drug Zantac From Market
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable human carcinogen, the U.S. Food and Drug Administration said Wednesday.
This is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2020 Category: Pharmaceuticals Source Type: news
FDA orders Zantac, other heartburn drugs removed from market due to NDMA contamination
The U.S. Food and Drug Administration ordered drugmakers to remove all prescription and over-the-counter products containing the agent ranitidine from the market immediately due to possible contamination. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 1, 2020 Category: Consumer Health News Source Type: news
